Correlation between NGF/TrkA and microvascular density in human pterygium

International Journal of Experimental Pathology

Volumn 90, Issue 6, 2009, Pages 615-620

  Ribatti, Domenico ^a   Nico, Beatrice ^a   Perra, Maria Teresa ^b   Maxia, Cristina ^b   Piras, Franca ^b   Murtas, Daniela ^b   Crivellato, Enrico ^c   Sirigu, Paola ^b  

^a UNIVERSITY OF BARI MEDICAL SCHOOL   (Italy)

^b UNIVERSITY OF CAGLIARI   (Italy)

^c UNIVERSITY OF UDINE   (Italy)

Author keywords

Angiogenesis; Nerve growth factor; Pterygium; TrkA

Indexed keywords

CD31 ANTIGEN; LYMPHOCYTE ANTIBODY; NERVE GROWTH FACTOR; NERVE GROWTH FACTOR ANTIBODY; PROTEIN TYROSINE KINASE A; PROTEIN TYROSINE KINASE INHIBITOR;

ADULT; AGED; ANGIOGENESIS; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ELASTOSIS; EXTRACELLULAR MATRIX; FEMALE; FIBROSIS; HUMAN; HUMAN TISSUE; INFLAMMATORY INFILTRATE; MALE; MICROVASCULAR DENSITY; MICROVASCULATURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PTERYGIUM; SOLAR RADIATION; ULTRAVIOLET RADIATION;

ADULT; AGED; CONJUNCTIVA; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICROVESSELS; MIDDLE AGED; NERVE GROWTH FACTOR; PTERYGIUM; RECEPTOR, TRKA; STAINING AND LABELING;

EID: 71449118107     PISSN: 09599673     EISSN: 13652613     Source Type: Journal    
DOI: 10.1111/j.1365-2613.2009.00665.x     Document Type: Article

References (27)

1. Aspiotis M., Tsanou E., Gorezis S. et al. (2007) Angiogenesis in pterygium: study of microvessel density, vascular endothelial growth factor and thrombospondin-1. Eye 21, 1095 1101.
2. Bahar I., Kaiserman I., Mc Allum P., Rootman D., Slomovic A. (2008) Subconjunctival bevacizumab injection for corneal neovascularization in recurrent pterygium. Curr. Eye Res. 33, 23 28. (Pubitemid 351156952)
3. Cantarella G., Lempereur L., Presta M. et al. (2002) Nerve growth factor-endothelial cell interaction leads to angiogenesis in vitro and in vivo. FASEB J. 16, 1307 1309.
4. Cassiman D., Denef C., Desnet V.J., Roskams T. (2001) Human and rat hepatic stellate cells express neurotrophins and neurotrophins receptors. Hepatology 33, 148 158. (Pubitemid 32016897)
5. Di Girolamo N., Kumar R.K., Coroneo M.T., Wakefield D. (2002) UVB-mediated induction of interleukin-8 and -8 in pterygia and cultured human pterygium epithelial cells. Invest. Ophthalmol. Vis. Sci. 43, 3430 3437.
6. Di Girolamo N., Wakefield D., Coroneo M.T. (2006) UVB-mediated induction of cytokines and growth factors in pterygium epithelial cells involves cell surface receptors and intracellular signaling. Invest. Ophthalmol. Vis. Sci. 47, 2430 2437.
7. Di Girolamo N., Sarrias M., Chui J., Cheema H., Coroneo M.T., Wakefield D. (2008) Localization of the low-affinity nerve growth factor receptor p75 in human limbal epithelial cells. J. Cell Mol. Med. 12, 2799 2811.
8. Ebendal T. (1992) Function and evolution in the NGF family and its receptors. J. Neurosci. Res. 32, 461 470.
9. Esquenazi S. (2005) Treatment of early pterygium recurrence with topical administration of interferon alpha. Can. J. Ophthalmol. 40, 185 187.
10. Hosseini H., Najabat M., Khalili M.R. (2007) Bevacizumab (Avastin) as a potential adjunct in the management of pterygia. Med. Hypothesis 69, 925 927. (Pubitemid 47248101)
11. Kria L., Ohira A., Amemiya T. (1996) Immunohistochemical localization of basic fibroblast growth factor, platelet derived growth factor, transforming growth factor beta and tumor necrosis factor alpha in the pterygium. Acta Histochem. 98, 195 201.
12. Kria L., Ohira A., Amemiya T. (1998) TNP-470 (a fungus-derived inhibitor of angiogenesis) reduces proliferation of cultured fibroblasts isolated from primary pterygia: a possible drug therapy for pterygia. Curr. Eye Res. 17, 986 993.
13. Lazarovici P., Marcinkiewicz C., Lelkes P.I. (2006) Cross talk between the cardiovascular and nervous systems: neurotrophic effects of vascular endothelial growth factor (VEGF) and angiogenic effect of nerve growth factor (NGF)-implications in drug development. Curr. Pharm. Design 12, 2609 2622.
14. Lee D.H., Cho H.J., Kim J.T., Choi J.S., Joo C.K. (2001) Expression of vascular endothelial growth factor and inducible nitric oxide synthase in pterygia. Cornea 20, 738 742.
15. Levi-Montalcini R. (1987) The nerve growth factor 35 years later. Science 237, 1154 1162.
16. Levi-Montalcini R., Aloe L., Alleva E. (1990) A role for nerve growth factor in nervous, endocrine and immune system. Prog. Neuroendocrinol. Immunol. 1, 1 10.
17. Marcovich A.L., Morad Y., Sandbank J. et al. (2002) Angiogenesis in pterygium: morphometric and immunohistochemical study. Curr. Eye Res. 25, 17 22.
18. Minischetti M., Vacca A., Ribatti D. et al. (2000) TNP-470 and recombinant human interferon-alpha2a inhibit angiogenesis synergistically. Br. J. Haematol. 109, 829 837.
19. Nico B., Mangieri D., Benagiano V., Crivellato E., Ribatti D. (2008) Nerve growth factor as an angiogenic factor. Microvasc. Res. 75, 135 141.
20. Raychaudhuri S.K., Raychaudhuri S.P., Weltman H., Farber E.M. (2001) Effect of nerve growth factor on endothelial cell biology: proliferation and adherence molecule expression on human dermal microvascular endothelial cells. Arch. Dermatol. Res. 293, 291 295.
21. Ribatti D., Crivellato E., Roccaro A.M., Ria R., Vacca A. (2004) Mast cell contribution to angiogenesis related to tumor progression. Clin. Exp. Allergy 34, 1660 1664.
22. Ribatti D., Nico B., Maxia C. et al. (2007) Neovascularization and mast cells with tryptase activity increase simultaneously in human pterygium. J. Cell Mol. Med. 11, 585 589.
23. Seifert P. Sekundo W. (1998) Capillaries in the epithelium of pterygium. Br. J. Ophtalmol. 82, 77 81.
24. Seo K., Choi J., Park M., Rhee C. (2001) Angiogenesis effects of nerve growth factor (NGF) on rat corneas. J. Vet. Sci. 2, 125 130.
25. Sidky Y.A. Borden E.C. (1987) Inhibition of angiogenesis by interferons: effects on tumor- and lymphocyte-induced vascular responses. Cancer Res. 47, 5155 5161.
26. Steinle J.J. Granger H.J. (2003) Nerve growth factor regulates human choroidal, but not retinal, endothelial cell migration and proliferation. Auton. Neurosci. 108, 57 62.
27. Tabakman R., Lecht S., Sephanova S., Arien-Zakay H., Lazarovici P. (2004) Interactions between the cells of the immune and nervous system: neurotrophins and neuroprotection mediators in CNS injury. Prog. Brain Res. 146, 387 401.